State Street Global Advisors (SSGA) announced today that the
SPDR® S&P Biotech ETF (NYSE: XBI), received payment as an
authorized claimant from a class action settlement related to Human
Genome Sciences, Inc.
The total amount payable to the Fund is listed below. When the
Fund calculates its net asset value (“NAV”) per share on Tuesday,
October 14, 2014, it is estimated that the Fund’s NAV will be
impacted by the receipt of the payment in the amount stated below
based on the shares outstanding as of October 10, 2014.
Fund
Settlement Payment
Shares Outstanding as of
October 10, 2014
Per Share Amount
SPDR® S&P Biotech ETF $856,233
7,250,000 $0.1181
Source: State Street Bank and Trust Co.
State Street manages more than $413 billion* in SPDR ETF assets
worldwide (as of June 30, 2014) and is one of the largest ETF
providers in the US and globally.
About State Street Global Advisors
State Street Global Advisors (SSGA) is a global leader in asset
management. The firm is relied on by sophisticated investors
worldwide for its disciplined investment process, powerful global
investment platform and access to every major asset class,
capitalization range and style. SSGA is the asset management
business of State Street Corporation, one of the world’s leading
providers of financial services to institutional investors.
* Assets under management include the assets of the SPDR® Gold
ETF (approximately $33 billion as of June 30, 2014), for which
State Street Global Markets, LLC, an affiliate of SSGA, serves as
the distribution agent.
Note to Editors: SPDR® Exchange Traded Funds
SPDR ETFs are a comprehensive family spanning an array of
international and domestic asset classes. SPDR ETFs provide
professional investors with the flexibility to select investments
that are precisely aligned to their investment strategy. Recognized
as the industry pioneer, State Street—in partnership with the
American Stock Exchange—created the first ETF in 1993 (SPDR S&P
500 – Ticker SPY). Since then, we’ve sustained our place as an
industry innovator through the introduction of many ground-breaking
products, including first-to-market successes with
gold, international real estate, international fixed income and
sector ETFs. SPDR ETFs are managed or marketed by SSGA or SSGA
Funds Management, Inc, a registered investment adviser and wholly
owned subsidiary of State Street Bank and Trust Company.
Risks associated with equity investing include stock values
which may fluctuate in response to the activities of individual
companies and general market and economic conditions.
The information provided does not constitute investment advice
and it should not be relied on as such. It should not be considered
a solicitation to buy or an offer to sell a security. It does not
take into account any investor's particular investment objectives,
strategies, tax status or investment horizon. You should consult
your tax and financial advisor.
All material has been obtained from sources believed to be
reliable. There is no representation or warranty as to the accuracy
of the information and State Street shall have no liability for
decisions based on such information.
"SPDR" is a registered trademark of Standard & Poor’s
Financial Services LLC ("S&P") and has been licensed for use by
State Street Corporation. No financial product offered by State
Street Corporation or its affiliates is sponsored, endorsed, sold
or promoted by S&P or its Affiliates, and S&P and its
affiliates make no representation, warranty or condition regarding
the advisability of buying, selling or holding units/shares in such
products. Further limitations and important information that could
affect investors' rights are described in the prospectus for the
applicable product.
Investing involves risk including the risk of loss of
principal.
The whole or any part of this work may not be reproduced, copied
or transmitted or any of its contents disclosed to third parties
without State Street's express written consent.
Non-diversified funds that focus on a relatively small number of
securities tend to be more volatile than diversified funds and the
market as a whole.
ETFs trade like stocks, are subject to investment risk,
fluctuate in market value and may trade at prices above or below
the ETFs net asset value. Brokerage commissions and ETF expenses
will reduce returns.
Because of their narrow focus, sector funds tend to be more
volatile than funds that diversify across many sectors and
companies.
The Fund invests by sampling the Index, holding a range of
securities that, in the aggregate, approximates the full Index in
terms of key risk factors and other characteristics. This may cause
the fund to experience tracking errors relative to performance of
the Index.
Distributor: State Street Global Markets, LLC, member FINRA,
SIPC, a wholly owned subsidiary of State Street Corporation.
References to State Street may include State Street Corporation and
its affiliates. Certain State Street affiliates provide services
and receive fees from the SPDR ETFs.
ALPS Distributors, Inc., a registered broker-dealer, is
distributor for SPDR S&P 500, SPDR S&P MidCap 400 and SPDR
Dow Jones Industrial Average, and all unit investment trusts. ALPS
Distributors, Inc. is not affiliated with State Street Global
Markets, LLC.
Before investing, consider the funds’ investment objectives,
risks, charges and expenses. To obtain a prospectus which contains
this and other information call 1-866-787-2257 or visit
www.spdr.com. Read it carefully.
CORP-1117
Expiration date: 10/31/2015
State Street CorporationElizabeth Bartlett, +1 617 662
2903www.statestreet.com@StateStreet
SPDR S&P Biotech (AMEX:XBI)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
SPDR S&P Biotech (AMEX:XBI)
Historical Stock Chart
Von Dez 2023 bis Dez 2024
